Hepatitis B is a virus that attacks the liver. It can be transmitted through contact with blood or bodily fluids from an infected person. Over 350 million people worldwide have chronic hepatitis B. While some experience no symptoms, it can lead to liver cirrhosis, liver failure, and liver cancer if left untreated. Getting vaccinated is the best way to prevent hepatitis B infection and testing is important for detection and treatment. Living with chronic hepatitis B requires lifelong management.
Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisdayNimzingLadep
Simply laid out sides about hepatitis, in particular, hepatitis B as part of public health education that was presented to a mixture of the public and professionals.
Cure for hepatitis B - Is this attainable with current treatments?NimzingLadep
Description of problem of how difficult the hepatitis B virus is to be eliminated due to the various biological make up of the virus. Then a historical overview of drug development and treatment of HBV. Targets for successful elimination of HBV were mentioned, ending with current investigations at finding a cure.
Consider contacting us for eLearning products at www.worthy-works.com; info@worthy-works.com
all information about
it include :-
1- DEFINITION
2- SIGNS AND SYMPTOMS
3- MECHANISM
4- RISK FACTOR
5- COMPLICATIONS
6- PRECAUTION
7- PREVENTION
8- EPIDEMIOLOGY
9- TREATMENT
and finally video about the mechanism of action
if you van not open it
hit this link
https://www.youtube.com/watch?v=ZuUfGeoN_cw
i hope it meet what you want
Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisdayNimzingLadep
Simply laid out sides about hepatitis, in particular, hepatitis B as part of public health education that was presented to a mixture of the public and professionals.
Cure for hepatitis B - Is this attainable with current treatments?NimzingLadep
Description of problem of how difficult the hepatitis B virus is to be eliminated due to the various biological make up of the virus. Then a historical overview of drug development and treatment of HBV. Targets for successful elimination of HBV were mentioned, ending with current investigations at finding a cure.
Consider contacting us for eLearning products at www.worthy-works.com; info@worthy-works.com
all information about
it include :-
1- DEFINITION
2- SIGNS AND SYMPTOMS
3- MECHANISM
4- RISK FACTOR
5- COMPLICATIONS
6- PRECAUTION
7- PREVENTION
8- EPIDEMIOLOGY
9- TREATMENT
and finally video about the mechanism of action
if you van not open it
hit this link
https://www.youtube.com/watch?v=ZuUfGeoN_cw
i hope it meet what you want
Hepatitis And Hiv Co Infection Tonia Poteat 060508elfaye
A presentation by Tonia Poteat from the CDC Global AIDS Project on the topic of Hepatitis B & C and HIV Co-infection. This webcast was presented live to ECHO (Evaluation Center for HIV and Oral Health) grantees on June 5, 2008.
Presentation about hepatitis with small detailed informations. It contains mainly pictures which help the better understanding of the topic. After a short classification, detailed explanations about hepatitis A, B, C, D and E.
what you need to know about the liver ?
What is Hepatitis ?
Types of hepatitis
Hepatitis C virus
History & Statics
Causes
Prevention
Concequences
Symptoms
Analysis
Behaving with infected people
vaccine
Genotypes
Treatments
Management
Summary
Dr Ranjith Pieris, Consultant Gastroenterologist and Hepatologist, NHSL. World Hepatitis Day was organized by the Sri Lanka College of Venereologists on world hepatitis day on 28 July 2015 at BMICH
Hepatitis And Hiv Co Infection Tonia Poteat 060508elfaye
A presentation by Tonia Poteat from the CDC Global AIDS Project on the topic of Hepatitis B & C and HIV Co-infection. This webcast was presented live to ECHO (Evaluation Center for HIV and Oral Health) grantees on June 5, 2008.
Presentation about hepatitis with small detailed informations. It contains mainly pictures which help the better understanding of the topic. After a short classification, detailed explanations about hepatitis A, B, C, D and E.
what you need to know about the liver ?
What is Hepatitis ?
Types of hepatitis
Hepatitis C virus
History & Statics
Causes
Prevention
Concequences
Symptoms
Analysis
Behaving with infected people
vaccine
Genotypes
Treatments
Management
Summary
Dr Ranjith Pieris, Consultant Gastroenterologist and Hepatologist, NHSL. World Hepatitis Day was organized by the Sri Lanka College of Venereologists on world hepatitis day on 28 July 2015 at BMICH
HIV, AIDS AND STD's
HIV
HIV stands for human immunity deficiency virus. HIV weakens the body immune system by entering into white blood cell (lymphocytes) and binds itself to chromosome and integrates into the genetic material. The virus now multiplies very fast using genetic materials of White Blood Cells. The daughter virus invades White Blood Cells destroy and kill them. As more White Blood Cells are killed the body becomes less and less fight against disease. Patient with aids are prone to opportunistic infection caused by fungi, bacteria and protozoa.
In nutshell people with AIDS die with disease their body cannot resist. These diseases are referred to as opportunistic infection. E.g. tuberculosis, severe diarrhea, skin cancer and pneumonia.
AIDS
AIDS stand for; Acquire Immune Deficiency Syndrome. For someone with AIDS T-helper fall below.
the T-helper count for health person range between 450 and 1200
CAUSES
AIDS is viral infection caused by a strain of a virus called HIV. HIV means Human Immunodeficiency Virus. HIV mainly found in body fluids such as blood, semen and vaginal secretion. Also traces of HIV found on saliva, tear and sweat
Primary stage (window stage) : It does not show any symptoms except for slight flu HIV test result is negative
A-symptomatic stage : Has no symptoms but the HIV test is positive
Full blown aids : Where by one gets various opportunistic infections and diseases
SEXUALLY TRANSMITTED INFECTION
These are infection, which are transmitted through sexually contact during sexually intercourse. Sexually transmitted disease are also referred to as venereal disease
RELATIONSHIP BETWEEN HIV, AIDS AND STD’s
HIV is sexually transmitted. Having STD's can increase risk of acquiring and transmitting HIV.
Some STI’s such as chlamydia cause open sores in the skin and become exit point into and from the brood stream of HIV.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Hepatitis B by Roel Tolentino
1. HEPATITIS B AND YOU
Prof. Roel Tolentino, MD, MBA
FACS, FPCS, FPSGS, FPSO, FMOSP
TV, Radio and Lay Health Educator
Professor Level IV
March 11, 2020 (Wed.), 12nn
10F Two/Neo Building
3rd Ave, BGC, Taguig City
2. Memorial Sloan Kettering Cancer Center (NYC)
University Hospitals of Columbia University and
Cornell Medical College (NYC)
MD Anderson Cancer (Texas)
Beijing Cancer Hospital (China)
Chongqing Medical University (China)
Suining Central Hospital (China)
De La Salle University – BS. Biology;
Medicine
Manila Med – General Surgery
SLMC – Surgical Oncology
Ateneo GSB - MBA
Prof. Roel Tolentino, MD, MBA
3. HEPATITIS B AND YOU
Prof. Roel Tolentino, MD, MBA
FACS, FPCS, FPSGS, FPSO, FMOSP
TV, Radio and Lay Health Educator
Professor Level IV
March 11, 2020 (Wed.), 12nn
10F Two/Neo Building
3rd Ave, BGC, Taguig City
4. What is the Liver?
What is Hepatitis B?
Transmission
Global/Local Impact
Test, vaccinate, treat!
Living with Chronic
Hepatitis B
FAQ
Resources
5. Hepatitis B is Serious – Global
Impact
• It’s a common disease!
• Over 350 million people in the world have
chronic hepatitis B.
8. Hepatitis B is a germ (virus) that gets into
your body and attacks your liver.
Hepatitis B Virus
What is hepatitis B?
9. What is the Liver?
• What does it do?
• Cleans your blood
• Helps you digest food
• Helps your body fight infections
10.
11.
12.
13. How is Hepatitis B Spread?
• From a mother passing the
hepatitis B virus to their baby
during birth
14. How is Hepatitis B Spread?
• By having unprotected sex
with a person who has the
hepatitis B virus
15. How is Hepatitis B Spread?
• By using unsterilized needles for
tattoos, body piercings, injection
drug use, or acupuncture
16. How is Hepatitis B Spread?
• By sharing shaving razors, toothbrushes, or
other personal items that may come into
contact with blood
17. How Hepatitis B is NOT Spread
hugging
holding hands
sharing food
breastfeeding
kissing
living with an infected person
18. Acute vs. Chronic Hepatitis B
• Acute: initial infection with the hepatitis B
virus
• Chronic: the hepatitis B virus remains in the
blood for more than 6 months
19. Acute vs. Chronic Hepatitis B
• The younger a person is first exposed to the
hepatitis B virus, the more likely they’ll develop
chronic hepatitis B
20. Why Do We Care About Chronic Hepatitis
B?
Chronic
Hepatitis
B
Liver
cirrhosis
Liver
failure
Liver
cancer
21.
22. Chronic Hepatitis B is Silent
Threat
• Half of all people with chronic hepatitis
B show no symptoms.
23. Chronic Hepatitis B is Silent
Threat
• People who have the hepatitis B virus
may infect others without knowing it.
24. Chronic Hepatitis B is Silent
Threat
• People often find out they have the hepatitis
B virus after they get really sick, when it’s
usually too late or difficult to treat the
infection.
25.
26. • Chronic hepatitis B is one of the top 10
causes of death worldwide.
• The hepatitis B virus is 100 times more
infectious than HIV.
Hepatitis B is Serious – Global Impact
27. Protect Yourself And Your
Family!
• Hepatitis B can infect
EVERYONE, regardless of
age.
• By getting tested and
vaccinated, you can protect
your family.
28. Protect Yourself And Your
Family!
• If you test positive, ask your
doctor about your
treatment/management
options.
• Prevention is the best
approach to hepatitis B.
29. Importance of Testing
• The only way to know if you are infected with
the hepatitis B virus is to get tested!
• Not all routine blood panels test for hepatitis
B.
- Ask your doctor for the tests specific to
chronic hepatitis B
30. Importance of Testing
• People of all ages should be tested,
especially if you’re from areas of high
prevalence.
31. Importance of Testing
• Early detection can help:
- Prevent spread of the hepatitis B virus
- Identify appropriate treatment options
- Reduce risk for developing liver cancer
32. Importance of Prevention
• The most effective means of preventing
hepatitis B infection is through vaccination!
• You need all 3 shots to be protected
1st shot –
at any time
2nd shot –
1 month
after the 1st
3rd shot –
6 months
after the 1st
34. –NOT sharing needles or
personal care items that
may come into contact
with blood (toothbrushes,
razors, etc)
–Knowing your status!
Importance of Prevention
35. Living with Chronic Hepatitis B
• Chronic hepatitis B requires management.
• Ask your doctor about your concerns.
36. Living with Chronic Hepatitis B
–Understand your test results
–Avoid drinking alcohol and smoking
–Help prevent transmission
to others
Refer to map as visual. Although the U.S. is green, hepatitis B is important because of the large immigrant and refugee populations in the states
Picture does not appear unless you click with the mouse.
Stress the importance of preventing at an early age!
Stress the importance of preventing at an early age!
Transition into global and local impact to explain why we’re focusing on hepatitis B in this presentation
Transition into global and local impact to explain why we’re focusing on hepatitis B in this presentation
Transition into global and local impact to explain why we’re focusing on hepatitis B in this presentation
ALT (Alanine transaminase) to test for liver damage and AFP (alpha-fetoprotein) to screen for liver cancer.
Get help: Not all people chronically infected with hepatitis B need treatment. However, if your blood levels of ALT are elevated ongoing liver damage may be occurring. Appropriate management can reduce the risk of further liver damage and liver cancer.
Get Informed: People chronically infected with hepatitis B can enjoy completely normal lives, but need to take some necessary precautions. To prevent transmission to others, do not share toothbrushes, razors, injection or tattoo needles because they may be tainted with blood. Also, ensure that all members of your household are tested and vaccinated if they are not already immunized. If you are uncertain whether your partner is protected, the proper use of latex condoms is recommended. Pregnant women infected with hepatitis B must make sure the newborn receives hepatitis B immunoglobulin (HBIG) plus the first dose of the hepatitis B vaccine at birth, and then follow-up with the second dose at 1-2 months, and the third dose at 6 months. This will be 97% effective in protecting the newborn from becoming a carrier. Take control of your own health, learn about the management and treatments available for hepatitis B. Don't be fooled by advertisements for unproven methods of prevention and treatment.
ALT (Alanine transaminase) to test for liver damage and AFP (alpha-fetoprotein) to screen for liver cancer.
Get help: Not all people chronically infected with hepatitis B need treatment. However, if your blood levels of ALT are elevated ongoing liver damage may be occurring. Appropriate management can reduce the risk of further liver damage and liver cancer.
Get Informed: People chronically infected with hepatitis B can enjoy completely normal lives, but need to take some necessary precautions. To prevent transmission to others, do not share toothbrushes, razors, injection or tattoo needles because they may be tainted with blood. Also, ensure that all members of your household are tested and vaccinated if they are not already immunized. If you are uncertain whether your partner is protected, the proper use of latex condoms is recommended. Pregnant women infected with hepatitis B must make sure the newborn receives hepatitis B immunoglobulin (HBIG) plus the first dose of the hepatitis B vaccine at birth, and then follow-up with the second dose at 1-2 months, and the third dose at 6 months. This will be 97% effective in protecting the newborn from becoming a carrier. Take control of your own health, learn about the management and treatments available for hepatitis B. Don't be fooled by advertisements for unproven methods of prevention and treatment.
Treatment with either lamivudine, adefovir or entecavir (a pill taken once a day) or a course of interferon shots may be appropriate in this situation. These are the only four FDA-approved pills for chronic hepatitis B.